Insights

ASPL Developments in Pharmacy Law Seminar: Regulatory, Industry, and Legal Perspectives on the Future of the DSCSA

SupplySide West: Ingredient Claims and Legal Flames - an Interactive Workshop to Dodge Regulatory Heat

MAGI@home 2024: Collaboration Over Confrontation - CTA Negotiation Tips & Tricks

Diabetes Technology Meeting: Who Can Sell Your Data - a United States Perspective

HDA 2024 Traceability Seminar: Legal Perspectives for DSCSA Compliance Teams

NACDS Total Store Expo: The DSCSA and Chain Drug Stores - Recent Developments and the Future

National Association of Chain Drug Stores Total Store Expo Pharmacy Compliance Roundtable

NCURA Annual Meeting: Key Challenges in Navigating Research Misconduct Proceedings

Adolescent Meningococcal Vaccines: Impact and Potential Changes

Multipurpose Prevention Technology (MPT) Summit: Experiences from Other Fields to Help Address MPT Roadblocks

AHLA Annual Meeting 2024

BCBS Association: Legal and Regulatory Challenges in Psychedelic Research and Commercialization

CIRS: Vaccines for Adults – Increasing Access and Uptake

AHLA: Bigger Than COVID – the State of Vaccine Law

BCBS Association: The World of Emerging Therapies and Alternative Substances in Healthcare

NFID 2024 Annual Conference on Vaccinology Research: Variability in Implementation of Adolescent School Entry Requirements Following ACIP Recommendations

AHLA: Long-Awaited Federal Privacy Rules on Substance Use Disorder Treatment Records

ABA 2024 HIV Law & Practice Conference: HIV Healthcare – Developments and Possibilities

2024 NCICP: Legal Landscape for Vaccination

FDLI Food and Dietary Supplement Safety and Regulation: Dietary Supplement Regulatory Updates – Focus on Agency Enforcement

World Vaccine Congress: Washington 2024

APhA2024: The Inflation Reduction Act - Implications for Pharmacy

Rx Drug Pricing Boot Camp: An In-Depth Look at the Effects of the Genesis Case

Life Sciences AI Summit: Navigating FDA and EMA Directives - Shaping AI’s Role in the Life Sciences

Current Developments in Digital Health Technology and Regulation: More Than Medical Devices - Development and Use of Companion Apps for Pharmaceutical Products and Beyond

340B Coalition Winter Conference 2024: Contract Pharmacy Deeper Dive

NJSBA: Dietary Supplement Litigation - Nutraceuticals and the Law

Implications of the Genesis Federal Court Decision on 340B Patient Definition

World Vaccine Congress West Coast: How Are NITAGs & HTAs Thinking About Novel Antibody Products?

ASPL Developments in Pharmacy Law Seminar: Drug Supply Chain Security Act Changes and Implications for Dispensers

Pharmaceutical and Medical Device Ethics and Compliance Congress: Drug Pricing—Considerations Around Price Controls, Negotiation, and Access

IFEBP Employee Benefits Conference: The Future of Prescription Drug Pricing Policy

USCHA 2023: Understanding PrEP Access in the Wake of Braidwood

What Should Executives Know About Artificial Intelligence?

11th Annual Legal, Regulatory & Compliance Forum on Dietary Supplements: Class Action Boot Camp

What's Nyoo! 30 Years of Women in Clinical Research - What It Means for You

Health Law Professors Conference: Tying Health Outcomes to Legal Doctrines - the Pedagogical Value of Teaching Vaccine Law

BIO International Convention: The Future of the Vaccine Safety Net - Ensuring Equity, Access, Innovation, and the Business of Vaccines

Medicaid and Government Pricing Congress

Rx Drug Pricing Boot Camp: A Look into the Seismic Impact of Litigation on the 340B Drug Pricing Program

World Vaccine Congress 2023: How the COVID-19 Vaccines Marketplace Is Evolving and Its Impact on Other Vaccines

AHLA Telemedicine Webinar Series: Hot Topics in Tele-Behavioral Health

Trade Secrets, Restrictive Covenants, and No-Poach Agreements in Health Care

American Society for Pharmacy Law: Trends in Drug Spending, Pricing, and Pharmacy Reimbursement

NACDS: Pharmacy Compliance with the Drug Supply Chain and Security Act

National Vaccine Law Conference 2022

340B Coalition Summer Conference: Contract Pharmacy Compliance—Oversight by the Entity

Building Resilience Through Private-Public Partnerships: Moving on from COVID-19 - How Will We Improve Pandemic Preparedness?

NWABR Hybrid IRB Conference: Privacy Pile-Up—Making Sense of Multiple Frameworks for Research Participant Privacy and Data Protection

American Society for Pharmacy Law: An Overview of Changes to Claw Backs in CMS’ Part D Final Rule

Medication Intelligence Summit 2022: Pharmacy Procurement Trends and Gaps

Hatch-Waxman Litigation in the District of New Jersey: A Primer for the Jurist and the Practitioner

ABA: FemTech Revolution—Technology Innovation to Address Gaps in Women's Health

Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond

AHLA Academic Medical Centers and Teaching Hospitals Law Institute 2022: Precision Medicine Studies—A Perfect Storm of Legal and Ethical Issues on the Line Between Treatment and Research

Online Pharmacy Prescriptions and Cybersecurity Best Practices

Healthcare General Counsel Virtual Forum: Interoperability – the Paradigm Shift Impacts on the Healthcare Data Ecosystem

New EU GDPR Standard Contractual Clauses: Deep Dive on Some Good News for U.S. Institutions and Pharma Companies

The Year in Review: Food and Dietary Supplement Industry Trends, Key Court Decisions, and Litigation Developments

340B Coalition Summer Conference 2021: Contract Pharmacy Basics

Author Happy Hour: Evolving Food and Dietary Supplement Class Action Suits

NBA Health Law Section: Exploring Careers in Health Law

FDLI Food and Dietary Supplement Safety and Regulation Conference: Dietary Supplements – Regulatory Challenges and Litigation Risks

Oppenheimer 31st Annual Healthcare Conference

Charitable Patient Assistance Programs: Ensuring Compliance - Establishing and Maintaining Arrangements with PAPs, Monitoring, and Auditing PAPs

FDLI Enforcement, Litigation, and Compliance Conference: FTC and SEC Litigation, Enforcement, and Application to FDA Authorities

2020 Advancing Ethical Research Conference: Complex Conflict of Interest - Understanding the COI Landscape

A New Justice, a New Court: How the Supreme Court Will Impact Employee Benefits

GCMI Virtual Experiential Learning Program: Reimbursement Pathways

Healthcare Compliance Training: An Overview of Federal and Private Health Care Programs for Drug and Device Manufacturers

Multi-Cancer Early Detection Through Novel Blood Tests: Developing Appropriate Regulatory and Reimbursement Pathways

Healthcare General Counsel Virtual Forum: Regulatory Change Threatening System Performance

APhA2020: The Drug Cost Controversy, Part 2 – What's Next?

Politics and Perspectives: Finding a Cure - Strategies for Tackling the High Cost of Prescription Drugs

Drug Pricing Transparency Congress: Strategize for 2020 - Breaking Down Transparency Headlines for Industry

US Regulation of Advertising, Promotion, and Labeling for Medical Devices: Intended Use & Off-Label Promotion

Jefferies 2019 Global Healthcare Conference

BIO 15th Annual Biotechnology Entrepreneurship Boot Camp: Reimbursement & Pricing Strategies

Bona Fide Service Fees and Fair Market Value Determination

Retail and Specialty Pharmacy: Strategic and Regulatory Considerations for Expanding Hospital Pharmacy Options

Epstein Becker Green's Annual Nashville Reception

Oppenheimer Healthcare Investor Conference: 2019 Healthcare Outlook – Key Legal, Legislative, and Regulatory Issues and Trends

HHS OIG Proposed Rule on the Safe Harbor for Pharmaceutical Rebates: The Issues and Impact

Food and Drug Law Institute: Developments in FDA Software Regulation

U.S. Healthcare Compliance Certification Program

Medicaid Drug Rebate Program: Role of Reimbursement Reform and Drug Pricing - Federal Level

AHLA Speaking of Health Law: Opioid Podcast Series - Hospital Perspective

BIO 14th Annual Biotechnology Entrepreneurship Boot Camp: Reimbursement & Pricing Strategies

Managed Care, Electronic Medical Records, Research Grants, Opioids, Drug Compounding, Drug Rehab and More

NJBIZ: The Opioid Discussion - Its Impact on the Workplace

Signs You May Have a Problem: White-Collar Crash Course Webinar Series

The Criminalization of Health Care: White-Collar Crash Course Webinar Series

What Are the Risks? Business Types Facing Increased Scrutiny: White-Collar Crash Course Webinar Series

"To Be a Legal Opinion or Not to Be a Legal Opinion?" That Is the In-House Communication Question: White-Collar Crash Course Webinar Series

AHLA: The Opioid Crisis - New Government Enforcement Initiatives and Future Implications for the Healthcare Industry

The Current Enforcement Environment: White-Collar Crash Course Webinar Series

FDLI Advertising and Promotion Conference: Risk Information in Direct-to-Consumer Broadcast Advertisements for Prescription Drugs

SupplySide West: FDA Lawsuits and Class Action Litigation in the Dietary Supplement Industry

NJHA and NJSBA Annual Joint Meeting: Focus on the Opioid Epidemic - Enforcement and Prevention

Specialty Pharma Association Regulatory Workshop: Pharmacovigilance Agreements

Next Generation Dx Summit: Technology Panel - Disruptive Technologies in Lab Medicine

2017 BIO International Convention: Coverage and Reimbursement Strategies for Biotech Products

Manufacturers' 340B Summit: "Specialty Pharmacy" and "Hot Topics Round Up"

American Bar Association: 2017 Midyear Meeting of the International Labor and Employment Law Committee

17th Annual Conference on Fraud and Abuse in the Sale and Marketing of Drugs, Devices, and Medical Technology: Regulatory and Legal Considerations When Using Social Media to Promote Drugs and Medical Devices

ASPL: 340B Drug Discount Program: Evolving Compliance Standards for Covered Entities and Contract Pharmacies in Wake of Proposed 340B Mega Guidance and Orphan Drug Ruling

Harvard T.H. Chan School of Public Health: Health Care and the Elections

2016 SupplySide West Conference: Developing and Substantiating Product Claims

First Annual National Association of Specialty Pharmacy (NASP) Specialty Pharmacy Law Conference

ACI's 28th FDA Boot Camp: Navigating the Approval Process for Drugs and Biologics

The Effect of the Average Manufacturer Price Final Rule on Drug Pricing and Contracting, Part 2: Opportunities and Barriers in Pharmaceutical Pricing

Correcting Misinformation in Social Media: When, Where, Why and How to Do It

The Effect of the Average Manufacturer Price Final Rule on Drug Pricing and Contracting, Part 1: The Impact of the AMP Final Rule: Legal, Operational, and Financial Considerations

340B Coalition 20th Annual Summer Conference

Managed Markets & Payer Marketing Strategies Conference: Regulatory Breakdown - Reviewing the AMP Final Rule

Seton Hall Law U.S. Healthcare Compliance Certification Program: An Overview of Federal Health Care Programs for Drug and Device Manufacturers

Health Insights Spring 2016 Conference: Are Innovative Payment Models the Solution to High Quality, More Affordable, Patient Centered Health Care?

16th Annual Employee Health Care Conference: Video vs. Phone in Telemedicine – Getting the Facts Straight

AHLA Physicians and Hospitals Law Institute